OPC-8212, a Quinoline Derivative, Counteracts the Reduction in Type III Collagen mRNA due to Lipopolysaccharides in Cultured Rat Cardiac Fibroblasts.

概要

論文の詳細を見る
Fibrillar collagen plays an essential role in ventricular remodeling, which is a major prognostic factor in various heart diseases. Inflammatory cytokines, including tumor necrosis factor α (TNFα), have been reported to play a role in various heart diseases and OPC-8212, a quinolinone derivative, has been demonstrated to reduce TNFα production. No studies have examined the effects of OPC-8212 on collagen metabolism in connection with inflammatory cytokine and growth factors. Using lipopolysaccharides as a tool to enhance TNFα, we examined the effects of OPC-8212 on the expression of type III collagen mRNA [α1(III)] in cultured neonatal rat cardiac fibroblasts. We also measured the concentration of TNFα and transforming growth factor β (TGFβ) in the cultured medium. Northern blot analysis revealed that LPS reduced the expression of α1(III) mRNA, and OPC-8212 counteracted this reduction (on average 25% above the reduced level by LPS stimulation). LPS enhanced the TNFα concentration in the medium, and OPC-8212 inhibited this enhancement. LPS increased the TGF-β1 concentration in the cultured medium, while OPC-8212 did not affect this increase. In summary, OPC-8212 counteracted the reduction in type III collagen mRNA expression by LPS accompanied by suppression of the increase in TNFα.
International Heart Journal刊行会の論文